Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 2207541-30-6
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Lenalidomide-I features a potent immunomodulatory scaffold with enhanced solubility and metabolic stability. This derivative integrates a critical imide moiety that enables selective binding to cereblon, modulating ubiquitin ligase activity. Designed for targeted protein degradation workflows, it offers improved handling under standard bench conditions.
Lenalidomide-I serves as a key intermediate in the synthesis of immunomodulatory drug candidates, leveraging its imide and amine functionalities for robust coupling reactions. It exhibits excellent bench stability and facilitates efficient incorporation into diverse heterocyclic scaffolds via standard amide bond formation or reductive amination protocols. The molecule’s defined stereochemistry and functional group tolerance enable reliable downstream transformations in medicinal chemistry workflows.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: